My entire problem with that call is based on KW statement that TD2 cannot be a part of the trial as they cannot handle 250 patients... this makes no sense because TD2 was at ASCO and even gave a presentation. We knew there were going to be 250 patients long before that! That doesn’t pass the smell check.
In my opinion that is not true. Something else happened. Because of that 1 thing, I can’t believe much else he said.
News 
Market Data 
Discover 
